Surgicel® (Fibrillar) in Non-variceal UGI Bleeding

NCT02054260 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-11-19

No results posted yet for this study

Summary

The aim of this study is to assess of effect of Surgicel® (Fibrillar) for preventing delayed bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal bleeding

Conditions

  • Non-variceal Upper Gastrointestinal Bleeding

Interventions

DRUG

Surgicel

Sponsors & Collaborators

  • Soonchunhyang University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02054260 on ClinicalTrials.gov